Who owns APREA THERAPEUTICS INC?
- Ticker: APRE
- CUSIP Number: 03836j201
Tip: Access positions for across all investors
Analyze quarterly positions in Aprea Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Aprea Therapeutics stock
Who bought or sold APREA THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
AIGH Capital Management | 539k | $3.5M | 54% | Mar 2024 |
|
Sio Capital Management | 277k | $1.9M | -1% | Mar 2024 |
|
Sphera Funds Management | 270k | $1.8M | 100% | Mar 2024 |
|
Nantahala Capital Management | 206k | $1.4M | 100% | Mar 2024 |
|
DAFNA Capital Management | 137k | $918k | 100% | Mar 2024 |
|
Vanguard Group | 116k | $776k | 234% | Mar 2024 |
|
Morgan Stanley | 27k | $179k | 84% | Mar 2024 |
|
Geode Capital Management | 20k | $135k | 16% | Mar 2024 |
|
HighTower Advisors | 14k | $93k | 100% | Mar 2024 |
|
BlackRock | 8.5k | $57k | -8% | Mar 2024 |
|
Royal Bank of Canada | 2.6k | $17k | -94% | Mar 2024 |
|
Group One Trading | 2.2k | $14k | 0% | Mar 2024 |
|
Bank of America Corporation | 1.6k | $11k | -52% | Mar 2024 |
|
Tower Research Capital | 1.1k | $7.5k | -36% | Mar 2024 |
|
Pnc Financial Services | 1.0k | $6.7k | 0% | Mar 2024 |
|
Advisor Group Holdings | 300.00 | $2.0k | 50% | Mar 2024 |
|
Wells Fargo & Company | 272.00 | $1.8k | 0% | Mar 2024 |
|
FMR | 161.00 | $1.1k | 100% | Mar 2024 |
|
WealthCollab | 158.00 | $1.1k | 0% | Mar 2024 |
|
Old Point Trust & Financial Services N A | 50.00 | $335.000000 | 100% | Mar 2024 |
|
UBS Group | 3.00 | $20.000100 | 0% | Mar 2024 |
|
Who sold out of Aprea Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Susquehanna International | Sep 2023 | 104k | $437k |
Worth Venture Partners | Dec 2023 | 87k | $410k |
Walleye Trading Advisors | Dec 2023 | 80k | $376k |
Jpmorgan Chase & Co | Dec 2023 | 5.00 | $24.000000 |